Procept Biorobotics (PRCT) Earnings Report, Financial Results, Financial analysis

Procept Biorobotics Corporation reported IV. Quarter net loss per share of $-0.36 compare to earnings per share of $0.37 in the same quarter a year ago and improved compare to net loss per share of $-0.51 realized in previous quarter.

*IV. Quarter*
Earnings Per Share	Revenues
$ -0.36	$ 24 Mill
$-0.73	$+32M

Procept Biorobotics's Revenue rose by -374.31 % in IV. Quarter (Dec 31 2022) year on year, to $24 million and advanced by 16.85 % sequentially.

Procept Biorobotics is Expected to report next financial results on May 05, 2023.

More on PRCT's Income Statement

PRCT's NET INCOME

Procept Biorobotics's in IV. Quarter recorded net loss of $-28.172 million, compare to net income of $14.103 million achieved in IV. Quarter a year ago.

Sequentially net loss advanced

More on PRCT's Growth

Procept Biorobotics Inventories
Inventories grew by 117.11 % to $29 million from IV. Quarter a year ago, sequentially inventories rose by 27.66 %. PRCT's Cash flow In IV. Quarter company's net cash flow was $52 million, capital expenditures grew by -638.25%, to $2 millions compare to same quarter a year ago and rose by -218.03% from III. Quarter (Sep 30 2022).

More on PRCT's Cash flow Statement

Earnings quality

Procept Biorobotics Corporation does not pay out common stock dividend.

In trailing twelve-month period Procept Biorobotics Corporation payed $ -1.81 cash per share, on a free-cash flow basis .

Book value fell by -10.38 % sequentially to $4.43 per share, -30.35% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 4.40 per share from $ 4.91.

Company repurchased 0.17 million shares or 0.39 % in IV. Quarter.

• More on PRCT's Dividends

Market Capitalization (Millions)	1,263
Shares Outstanding (Millions)	44
Total Debt (Millions $)	51
Revenue (TTM) (Millions $)	75
Net Income (TTM) (Millions $)	-87
Cash Flow (TTM) (Millions $)	0
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Procept Biorobotics Corporation does not pay out common stock dividend.

In trailing twelve-month period Procept Biorobotics Corporation had negative $ -1.81 cash flow per share, on a free-cash flow basis .

Book value fell by -10.38 % sequentially to $4.43 per share, -30.35% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 4.40 per share from $ 4.91.

Company repurchased 0.17 million shares or 0.39 % in IV. Quarter.

• More on PRCT's Balance Sheets

Market Capitalization (Millions)	1,263
Shares Outstanding (Millions)	44
Total Debt (Millions $)	51
Revenue (TTM) (Millions $)	75
Net Income (TTM) (Millions $)	-87
Cash Flow (TTM) (Millions $)	0
Capital Exp. (TTM) (Millions $)	0
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar DDL's Profile Stock Price DDL's Financials Business Description Fundamentals Charts & Quotes DDL's News Suppliers DDL's Competitors Customers & Markets Economic Indicators DDL's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Procept Biorobotics Corporation

PRCT's Financial Statements and Analysis